This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

Brian Lindman and Christopher Cook review the paradigm shift from passive watchful waiting to proactive management of severe ...

Michael Mack and Amy Abernathy discuss how to streamline research and accelerate timelines in order to provide timely care.

Michael Mack and Michael Borger outline the most important shifts and clarifications in the 2025 ESC/EACTS VHD guidelines.

REUP avoids the ethical issues and costs of other procurement and recovery methods. So far, outcomes are excellent.

Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab staff.

Despite receiving devices, education, and support, only one-third regularly took morning and night BP measurements as ...

With no difference in death or MI, Kevin Bainey says doctors can give medical therapy a good try before sending patients for ...

Clinicians who use the tool more often are less likely to order diagnostic tests and GDMT, even for HFrEF patients.

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

The dual approach, though rare, was linked to fewer 2-year MACE and lower long-term costs compared with angiography alone.

Cardio-oncologists should incorporate vascular prevention in their care, especially for those without protective hormones.